ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

Merck in Talks to Buy Indian Pharmaceutical Ingredients Maker Micro Labs - Report

Merck & Co. Inc. (MRK) is in talks to acquire Indian active pharmaceutical ingredients maker Micro Labs Ltd., the Financial Express reported Thursday, citing an unidentified person aware of the matter. The newspaper said Bangalore-based Micro Labs is a privately held company, founded and run by the Surana family. Micro Labs aims to achieve sales of about $1 billion by 2015, the report said, citing the company's website. A Merck India spokesperson declined to comment to the newspaper on any possible deal. Newspaper website: http://www.financialexpress.com Write to djn.in@dowjones.com

Stock News for Merck (MRK)
DateTimeHeadline
07/28/201508:23:48Merck Reports Better-Than-Seen Profits, Buy Of Cancer Drug Maker--Update
07/28/201508:20:10Merck Earnings Top Views Amid Cost Cuts
07/28/201508:12:33Merck Reports Better-Than-Seen Profits, Buy Of Cancer Drug Maker
07/28/201507:07:41Current Report Filing (8-k)
07/28/201507:00:00Merck Announces Second-Quarter 2015 Financial Results
07/28/201506:45:00Merck Enhances Immuno-Oncology Portfolio with Acquisition of...
07/28/201506:30:00Merck Announces U.S. Food & Drug Administration Acceptance of...
07/27/201508:30:00Merck Receives Positive CHMP Opinion for Investigational Antibiotic...
07/24/201516:14:52Current Report Filing (8-k)
07/23/201521:27:00MSD annonce que l’Agence européenne du médicament a accepté la d...
07/23/201519:10:00MSD annuncia l'accettazione da parte dell'Agenzia Europea dei...
07/23/201519:06:00MSD meldet Annahme des Zulassungsantrags für Grazoprevir/Elbasvir...
07/23/201513:35:12Bristol-Myers Revenue Boosted by Cancer Drug Opdivo
07/23/201511:02:00MSD Announces European Medicines Agency Acceptance of Marketing...
07/23/201511:02:00Merck Announces European Medicines Agency Acceptance of Marketing...
07/22/201513:28:00Merck Announces Fourth-Quarter 2015 Dividend
07/22/201507:00:00European Commission Approves Merck’s Anti-PD-1 Therapy, KEYTRUDA® (p...
07/22/201507:00:00Europäische Kommission erteilt Anti-PD-1-Therapie KEYTRUDA®...
07/22/201507:00:00La Commission européenne approuve le médicament à base d'anticorps an...
07/22/201507:00:00La Commissione europea approva KEYTRUDA® (pembrolizumab), la...

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad